<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Monitoring of prices in the EECA region | ITPCru</title>
	<atom:link href="https://itpc-eeca.org/en/category/monitoring-tsen-v-vetsa_en/feed/" rel="self" type="application/rss+xml" />
	<link>https://itpc-eeca.org/en/</link>
	<description>Международная коалиция по готовности к лечениюе</description>
	<lastBuildDate>Wed, 06 Mar 2019 14:30:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>On the way to 90: Analysis of procurement and provision of ARV drugs in seven countries of  Eastern Europe and Central Asia</title>
		<link>https://itpc-eeca.org/en/2019/03/06/on-the-way-to-90-analysis-of-procurement-and-provision-of-arv-drugs-in-seven-countries-of-eastern-europe-and-central-asia/</link>
					<comments>https://itpc-eeca.org/en/2019/03/06/on-the-way-to-90-analysis-of-procurement-and-provision-of-arv-drugs-in-seven-countries-of-eastern-europe-and-central-asia/#comments</comments>
		
		<dc:creator><![CDATA[Татьяна Хан]]></dc:creator>
		<pubDate>Wed, 06 Mar 2019 14:30:43 +0000</pubDate>
				<category><![CDATA[Monitoring of drug procurement]]></category>
		<category><![CDATA[Monitoring of prices in the EECA region]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://itpcru.org/?p=18251</guid>

					<description><![CDATA[ITPCru is proud to present its first regional report on procurement and provision of antiretroviral drugs in 7 countries of Eastern Europe and Central Asia in 2017. The report is based on a series of national reports implemented by patient organizations in the respective countries (Armenia, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Russia, Ukraine). The findings and recommendations]]></description>
										<content:encoded><![CDATA[<p>ITPCru is proud to present its first regional report on procurement and provision of antiretroviral drugs in 7 countries of Eastern Europe and Central Asia in 2017. The report is based on a series of national reports implemented by patient organizations in the respective countries (Armenia, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Russia, Ukraine).</p>
<p><span id="more-18251"></span></p>
<p>The findings and recommendations were used as a basis for discussions with stakeholders with the aime to optimize treatment regimens and increase treatment coverage. The original version in Russian can be found here. In 2019, a second report will be published, covering the situation with HIV and HCV drug procurement and provision in EECA in 2018.</p>
<iframe src="//docs.google.com/viewer?url=https%3A%2F%2Fitpc-eeca.org%2Fwp-content%2Fuploads%2F2019%2F03%2FOn-the-way-to-90-regional-report.pdf&hl=ru&embedded=true" class="gde-frame" style="width:100%; height:500px; border: none;" scrolling="no"></iframe>
<p class="gde-text"><a href="https://itpc-eeca.org/wp-content/uploads/2019/03/On-the-way-to-90-regional-report.pdf" data-mtli="mtli_filesize191MB" class="gde-link local-link">Скачать (PDF, 1.91MB)</a></p>
<style type="text/css">a[data-mtli~="mtli_filesize191MB"]:after {content:" (1.91 MB)"}</style><p>The post <a href="https://itpc-eeca.org/en/2019/03/06/on-the-way-to-90-analysis-of-procurement-and-provision-of-arv-drugs-in-seven-countries-of-eastern-europe-and-central-asia/">On the way to 90: Analysis of procurement and provision of ARV drugs in seven countries of  Eastern Europe and Central Asia</a> first appeared on <a href="https://itpc-eeca.org/en/">ITPCru</a>.</p>]]></content:encoded>
					
					<wfw:commentRss>https://itpc-eeca.org/en/2019/03/06/on-the-way-to-90-analysis-of-procurement-and-provision-of-arv-drugs-in-seven-countries-of-eastern-europe-and-central-asia/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>Coverage expansion: risks and opportunities. The findings of the ARV drugs procurement monitoring in 2017</title>
		<link>https://itpc-eeca.org/en/2018/05/28/coverage-expansion-risks-and-opportunities-the-findings-of-the-arv-drugs-procurement-monitoring-in-2017/</link>
					<comments>https://itpc-eeca.org/en/2018/05/28/coverage-expansion-risks-and-opportunities-the-findings-of-the-arv-drugs-procurement-monitoring-in-2017/#respond</comments>
		
		<dc:creator><![CDATA[Татьяна Хан]]></dc:creator>
		<pubDate>Mon, 28 May 2018 15:09:50 +0000</pubDate>
				<category><![CDATA[Monitoring of drug procurement]]></category>
		<category><![CDATA[Monitoring of prices in the EECA region]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://itpcru.org/?p=16506/</guid>

					<description><![CDATA[ITPCru has published their new report about the results of ARV drugs procurement monitoring in 2017. There are the following chapters in the report: ARVs procurement in Russia The list of the essential medicines The scope and structure of ARVs procured in 2017 The procurement structure by the class and type of the medicine The]]></description>
										<content:encoded><![CDATA[<p>ITPCru has published their new report about the results of ARV drugs procurement monitoring in 2017.<span id="more-16506"></span></p>
<p>There are the following chapters in the report:</p>
<ul>
<li>ARVs procurement in Russia</li>
<li>The list of the essential medicines</li>
<li>The scope and structure of ARVs procured in 2017</li>
<li>The procurement structure by the class and type of the medicine</li>
<li>The cost of ARVs in 2017</li>
<li>The number of patients on ART</li>
<li>The cost of the most common treatment regimens</li>
</ul>
<p>The report is available here:</p>
<iframe src="//docs.google.com/viewer?url=https%3A%2F%2Fitpc-eeca.org%2Fwp-content%2Fuploads%2F2018%2F05%2FARV-eng-cut-29.05.18.pdf&hl=ru&embedded=true" class="gde-frame" style="width:100%; height:500px; border: none;" scrolling="no"></iframe>
<p class="gde-text"><a href="https://itpc-eeca.org/wp-content/uploads/2018/05/ARV-eng-cut-29.05.18.pdf" data-mtli="mtli_filesize166MB" class="gde-link local-link">Скачать (PDF, 1.66MB)</a></p>
<style type="text/css">a[data-mtli~="mtli_filesize166MB"]:after {content:" (1.66 MB)"}</style><p>The post <a href="https://itpc-eeca.org/en/2018/05/28/coverage-expansion-risks-and-opportunities-the-findings-of-the-arv-drugs-procurement-monitoring-in-2017/">Coverage expansion: risks and opportunities. The findings of the ARV drugs procurement monitoring in 2017</a> first appeared on <a href="https://itpc-eeca.org/en/">ITPCru</a>.</p>]]></content:encoded>
					
					<wfw:commentRss>https://itpc-eeca.org/en/2018/05/28/coverage-expansion-risks-and-opportunities-the-findings-of-the-arv-drugs-procurement-monitoring-in-2017/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Таблица &#8220;Минимальные, максимальные и средневзвешенные цены на АРВ-препараты в РФ&#8221;</title>
		<link>https://itpc-eeca.org/en/2015/06/08/tablitsa-minimalnye-maksimalnye-i-srednevzveshennye-tseny-na-arv-preparaty-v-rf/</link>
					<comments>https://itpc-eeca.org/en/2015/06/08/tablitsa-minimalnye-maksimalnye-i-srednevzveshennye-tseny-na-arv-preparaty-v-rf/#respond</comments>
		
		<dc:creator><![CDATA[Татьяна Хан]]></dc:creator>
		<pubDate>Mon, 08 Jun 2015 12:08:49 +0000</pubDate>
				<category><![CDATA[Monitoring of drug procurement]]></category>
		<category><![CDATA[Monitoring of prices in the EECA region]]></category>
		<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://itpcru.org/2015/06/08/tablitsa-minimalnye-maksimalnye-i-srednevzveshennye-tseny-na-arv-preparaty-v-rf-2/</guid>

					<description><![CDATA[В таблице “Минимальные, максимальные и средневзвешенные цены на АРВ-препараты в РФ” отражены цены на все препараты для лечения ВИЧ-инфекции, закупленные в 2014 году, включая стоимость единицы (таблетки, капсулы, флакона), а также годового курса лечения одного пациента. Таблица может быть полезна для учреждений, осуществляющих закупки АРВ-препаратов в 2015 году, активистов, работающих в сфере доступа к лечению ВИЧ,]]></description>
										<content:encoded><![CDATA[<p>В таблице &#8220;Минимальные, максимальные и средневзвешенные цены на АРВ-препараты в РФ&#8221; отражены цены на все препараты для лечения ВИЧ-инфекции, закупленные в 2014 году, включая стоимость единицы (таблетки, капсулы, флакона), а также годового курса лечения одного пациента.</p>
<p><span id="more-13879"></span></p>
<p>Таблица может быть полезна для учреждений, осуществляющих закупки АРВ-препаратов в 2015 году, активистов, работающих в сфере доступа к лечению ВИЧ, а также всех заинтересованных сторон.</p>
<p>Скачать <a href="https://itpc-eeca.org/wp-content/uploads/2015/06/Min-Maks-Sred-kurs-tseny-tablitsa.pdf" data-mtli="mtli_filesize25048kB" class="local-link">таблицу</a>.</p>
<style type="text/css">a[data-mtli~="mtli_filesize25048kB"]:after {content:" (250.48 kB)"}</style><p>The post <a href="https://itpc-eeca.org/en/2015/06/08/tablitsa-minimalnye-maksimalnye-i-srednevzveshennye-tseny-na-arv-preparaty-v-rf/">Таблица “Минимальные, максимальные и средневзвешенные цены на АРВ-препараты в РФ”</a> first appeared on <a href="https://itpc-eeca.org/en/">ITPCru</a>.</p>]]></content:encoded>
					
					<wfw:commentRss>https://itpc-eeca.org/en/2015/06/08/tablitsa-minimalnye-maksimalnye-i-srednevzveshennye-tseny-na-arv-preparaty-v-rf/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
